Kular, Dalvir
Macdougall, Iain C. http://orcid.org/0000-0001-9098-8611
Funding for this research was provided by:
King's College London
Article History
Received: 20 August 2017
Revised: 28 October 2017
Accepted: 31 October 2017
First Online: 22 March 2018
Compliance with ethical standards
:
: Iain Macdougall has received consultancy fees, speaker fees, and research support from a number of manufacturers of HIF stabilizers, including FibroGen, Astellas, GlaxoSmithKline, Akebia, and Bayer. Dalvir Kular reports no conflict of interest.